Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Covid-19 Antibody Responses in Cystic Fibrosis
NCT05614336Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2022
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: SARS-COV-2 seroprevalence at 2 years. Started Jun 2022; status: completed.
Beyond the preview
Go deeper on NCT05614336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05614336.